Chemed Co. (NYSE:CHE) Shares Bought by XTX Topco Ltd

XTX Topco Ltd raised its position in Chemed Co. (NYSE:CHE) by 58.1% during the 1st quarter, according to its most recent filing with the SEC. The firm owned 1,187 shares of the company’s stock after buying an additional 436 shares during the quarter. XTX Topco Ltd’s holdings in Chemed were worth $638,000 as of its most recent filing with the SEC.

Several other institutional investors also recently bought and sold shares of CHE. Rice Hall James & Associates LLC acquired a new position in Chemed in the 1st quarter valued at $273,000. Raymond James Financial Services Advisors Inc. grew its stake in shares of Chemed by 13.3% during the 1st quarter. Raymond James Financial Services Advisors Inc. now owns 1,957 shares of the company’s stock worth $992,000 after purchasing an additional 230 shares during the period. American Century Companies Inc. grew its stake in shares of Chemed by 7.2% during the 1st quarter. American Century Companies Inc. now owns 2,018 shares of the company’s stock worth $1,022,000 after purchasing an additional 135 shares during the period. HighTower Advisors LLC grew its stake in shares of Chemed by 6.2% during the 1st quarter. HighTower Advisors LLC now owns 836 shares of the company’s stock worth $432,000 after purchasing an additional 49 shares during the period. Finally, Panagora Asset Management Inc. grew its stake in shares of Chemed by 495.0% during the 1st quarter. Panagora Asset Management Inc. now owns 2,261 shares of the company’s stock worth $1,145,000 after purchasing an additional 1,881 shares during the period. 94.25% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of equities analysts have recently weighed in on CHE shares. Royal Bank of Canada lowered their price target on shares of Chemed from $610.00 to $576.00 and set an “outperform” rating on the stock in a research note on Monday, July 31st. StockNews.com raised shares of Chemed from a “hold” rating to a “buy” rating in a research note on Wednesday, August 30th.

Chemed Stock Down 0.3 %

Chemed stock opened at $499.76 on Monday. Chemed Co. has a 52 week low of $430.16 and a 52 week high of $574.66. The firm’s 50-day simple moving average is $522.69 and its 200 day simple moving average is $533.13. The firm has a market capitalization of $7.54 billion, a PE ratio of 33.32, a P/E/G ratio of 3.02 and a beta of 0.53.

Chemed (NYSE:CHE) last released its quarterly earnings data on Wednesday, July 26th. The company reported $4.71 EPS for the quarter, missing the consensus estimate of $5.09 by ($0.38). Chemed had a return on equity of 34.65% and a net margin of 10.36%. The business had revenue of $553.80 million during the quarter, compared to analysts’ expectations of $562.54 million. During the same quarter in the prior year, the firm earned $4.84 earnings per share. Chemed’s quarterly revenue was up 4.2% on a year-over-year basis. On average, research analysts expect that Chemed Co. will post 19.14 EPS for the current fiscal year.

Chemed Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 5th. Shareholders of record on Monday, August 14th were issued a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a yield of 0.32%. This is a positive change from Chemed’s previous quarterly dividend of $0.38. The ex-dividend date of this dividend was Friday, August 11th. Chemed’s dividend payout ratio is 10.67%.

Insider Buying and Selling at Chemed

In other Chemed news, CEO Kevin J. Mcnamara sold 4,000 shares of the company’s stock in a transaction dated Thursday, August 3rd. The shares were sold at an average price of $516.43, for a total value of $2,065,720.00. Following the transaction, the chief executive officer now directly owns 115,571 shares in the company, valued at approximately $59,684,331.53. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. 4.03% of the stock is owned by insiders.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in two segments, VITAS and Roto-Rooter. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.